Related Experiment Video
Updated: Apr 10, 2026

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
Published on: November 8, 2024
Practical approach to pregnancy-associated thrombotic microangiopathies: navigating diagnostic challenges in
Meenupriya Arasu1, Viswanath S1, Rahul Kumar Anand1
1Anaesthesiology,Pain Medicine and Critical Care, All India Institute of Medical Sciences New Delhi, New Delhi, India.
Pregnancy can trigger thrombotic microangiopathy (TMA), a condition associated with high morbidity and mortality if treatment is delayed. Timely diagnosis remains challenging, particularly in resource-limited settings due to limited access to specialised assays. We present three cases of maternal TMA admitted to our tertiary care unit located in a developing country. One patient was a known case of hereditary thrombocytopenic purpura. Two other cases presented with TMA post-caesarean section complicated by sepsis and postpartum haemorrhage, respectively, and were diagnosed as pregnancy-associated TMA (likely complement-mediated haemolytic uraemic syndrome). Management decisions were largely based on clinical assessment and a resource-adapted pragmatic approach due to unavailability of specialised assays and eculizumab. All patients were treated with urgent therapeutic plasma exchange. This report emphasises the importance of recognising pregnancy-associated TMAs and tailoring the diagnosing and managing strategies to available resources.
Pregnancy can trigger thrombotic microangiopathy (TMA), a condition associated with high morbidity and mortality if treatment is delayed. Timely diagnosis remains challenging, particularly in resource-limited settings due to limited access to specialised assays. We present three cases of maternal TMA admitted to our tertiary care unit located in a developing country. One patient was a known case of hereditary thrombocytopenic purpura. Two other cases presented with TMA post-caesarean section complicated by sepsis and postpartum haemorrhage, respectively, and were diagnosed as pregnancy-associated TMA (likely complement-mediated haemolytic uraemic syndrome). Management decisions were largely based on clinical assessment and a resource-adapted pragmatic approach due to unavailability of specialised assays and eculizumab. All patients were treated with urgent therapeutic plasma exchange. This report emphasises the importance of recognising pregnancy-associated TMAs and tailoring the diagnosing and managing strategies to available resources.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

